TrialPloS one2016

Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.

Bonnie K Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.